Newport Pharmaceuticals Overview

  • Year Founded
  • 1970

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Newport Pharmaceuticals General Information

Description

Manufacturer of pharmaceutical products for the treatment of infectious diseases. The company offers inosine acedoben dimepranol, an immunomodulator drug as a drug substance indicated for the treatment of cell-mediated immune deficiencies associated with various viral infections.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Parent Company
Ewopharma
Corporate Office
  • Swords Enterprise Park Feltrim Road
  • County Dublin
  • Swords
  • Ireland
+353 (01) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newport Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Newport Pharmaceuticals‘s full profile, request access.

Request a free trial

Newport Pharmaceuticals Patents

Newport Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-529514-A0 A method for preparing imidazole compounds Active 07-Feb-1984
ES-8507509-A1 Amino-imidazole-5-carboxamide Inactive 07-Feb-1984
ES-8500278-A1 Amino-imidazole-5-carboxamide Inactive 06-Jun-1983
ES-523023-A0 A method for preparing imidazole compounds Active 06-Jun-1983
DE-3382080-D1 Method for producing imidazole compounds. Inactive 24-May-1983 C07D241/06
To view Newport Pharmaceuticals’s complete patent history, request access »

Newport Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Alan Johns General Manager
Gustavo Cubero Chief Commercial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Newport Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newport Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Newport Pharmaceuticals‘s full profile, request access.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »